Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 300
Avg Vol 387
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 38%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Noveris Health Sciences Inc., a biotechnology company, engages in the research, development, and commercialization of psilocybin products to treat mental health conditions. The company primarily focuses on treating nicotine addiction and post-traumatic stress disorder. It also develops MYCO-005, MYCO-006, and MYCO-007 for MDMA and psilocybin analogs. The company has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic a...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 604 687 2038
Address:
1075 West Georgia Street, Suite 1890, Vancouver, Canada
Latest News on MYCOF
No data available.